Monaghan Medical Competitors and Similar CompaniesClear all

Monaghan Medical's competitors and similar companies include Southern Prosthetic Supplies, Nipponflex, Richard Wolf and Zhejiang Gongdong Medical Technology.

	Monaghan Medical Monaghan Medical is a company that manufactures aerosol drug delivery devices and respiratory management products.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Nipponflex Nipponflex is a company that specializes in the development of the scientific sleeping system.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.
Founding Date	Founding Date 2000	Founding Date 1951	Founding Date 1987	Founding Date 1906	Founding Date 1985
Type	Type Private	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices
Locations	Locations Plattsburgh, US HQ Plattsburgh, US	Locations Alpharetta, US HQ Fresno, US	Locations Maringá, BR HQ Aracaju, BR Brasilia, BR Cabedelo, BR Campo Grande, BR Contagem, BR Cuiabá, BR see more	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more	Locations Taizhou, CN HQ Riverside, US
Employees	Employees 1141% increase	Employees 1981% increase	Employees 1,586	Employees 1,800	Employees 1,693
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €249.9m (FY, 2021)	Revenue (est.) ¥1.1b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €70.1m (FY, 2021)	Cost of goods ¥749.5m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €179.7m (FY, 2021)	Gross profit ¥352.8m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income €4.1m (FY, 2021)	Net income ¥171.5m (FY, 2024)